Citi Upgrades FibroGen (FGEN) to Buy

December 18, 2018 4:59 PM EST
Get Alerts FGEN Hot Sheet
Price: $21.56 +2.47%

Rating Summary:
    5 Buy, 8 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 4 | New: 24
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Citi analyst Joel Beatty upgraded FibroGen (NASDAQ: FGEN) from Neutral to Buy with a price target of $71.00.

The analyst sees an opportunity following the recent pullback and head of Roxa Phase 3 data in the first half of 2019.

For an analyst ratings summary and ratings history on FibroGen click here. For more ratings news on FibroGen click here.

Shares of FibroGen closed at $38.99 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Hot Upgrades, Upgrades

Related Entities

Citi